Article
Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma
1 Jan 2017
Abstract excerpt
OBJECTIVES: Programmed death 1 (PD-1) is an immunoinhibitory receptor and has been identified as a new target for immunotherapy in cancer. Here we report the expression of PD-1 ligand 1 (PD-L1) in surgically resected gastric cancer. MATERIALS AND METHODS: We examined formalin-fixed tumor samples from 144 gastric cancer patients with a primary diagnosis of gastric carcinoma. Immunohistochemistry was used to detect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
